BDBM50235441 4-(1-(3-isopropylbenzyl)piperidin-4-yl)-1-(oxazol-2-yl)butan-1-one::CHEMBL428874
SMILES: CC(C)c1cccc(CN2CCC(CCCC(=O)c3ncco3)CC2)c1
InChI Key: InChIKey=NFPIJCNXUVBLSI-UHFFFAOYSA-N
Data: 2 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fatty-acid amide hydrolase 1 (Homo sapiens (Human)) | BDBM50235441![]() (4-(1-(3-isopropylbenzyl)piperidin-4-yl)-1-(oxazol-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 3.60 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL | Assay Description Inhibition of FAAH | J Med Chem 51: 7327-43 (2009) Article DOI: 10.1021/jm800311k BindingDB Entry DOI: 10.7270/Q2J67HT8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty-acid amide hydrolase 1 (Homo sapiens (Human)) | BDBM50235441![]() (4-(1-(3-isopropylbenzyl)piperidin-4-yl)-1-(oxazol-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL | Assay Description Inhibition of human FAAH | Bioorg Med Chem Lett 18: 2109-13 (2008) Article DOI: 10.1016/j.bmcl.2008.01.091 BindingDB Entry DOI: 10.7270/Q2708287 | |||||||||||
More data for this Ligand-Target Pair |